title: Unexpected erythroid and cytogenetic responses after discontinuation of a short course of lenalidomide as a result of severe skin rash in a patient with 5q syndrome.
authors.affiliation: Sapienza University, Rome, Italy.
authors.forename: Massimo
authors.initials: M
authors.lastname: Breccia
authors.forename: Laura
authors.initials: L
authors.lastname: Cannella
authors.forename: Roberto
authors.initials: R
authors.lastname: Latagliata
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Loglisci
authors.forename: Adriano
authors.initials: A
authors.lastname: Salaroli
authors.forename: Michelina
authors.initials: M
authors.lastname: Santopietro
authors.forename: Esther N
authors.initials: EN
authors.lastname: Oliva
authors.forename: Giuliana
authors.initials: G
authors.lastname: Alimena
mesh_terms: D000368:Aged; D000748:Anemia, Macrocytic / Q000097:blood / Q000188:drug therapy / Q000235:genetics; D002872:Chromosome Deletion; D002895:Chromosomes, Human, Pair 5 / Q000235:genetics; D003582:Cytogenetics; D041905:Erythroid Cells / Q000187:drug effects*; D005076:Exanthema / Q000139:chemically induced*; D006801:Humans; D000077269:Lenalidomide; D012269:Ribosomal Proteins / Q000235:genetics; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: C526722:RPS14 protein, human; D012269:Ribosomal Proteins; D013792:Thalidomide; D000077269:Lenalidomide